Skip to main content

Table 1 Baseline Demographic information of patient with CSM

From: Clinical impact and imaging results after a modified procedure of ACDF: a prospective case-controlled study based on ninety cases with two-year follow-up

Variable

Spread group (n = 48)

None-spread group (n = 42)

P Value

Age, mean ± SD, y

59.54 ± 17.65

60.07 ± 15.21

.880

Female, No. (%)

28 (58.33)

25 (59.52)

.909

Hypertension, No. (%)

29 (60.42)

27 (64.29)

.706

Atrial fibrillation, No. (%)

18 (37.50)

17 (40.48)

.773

Smokers, No. (%)

21 (43.75)

19 (45.24)

.887

Diabetes, No. (%)

12 (25.00)

9 (21.43)

.689

Operated level, No.

48

42

 

 C3/C4, No. (%)

6

5

.868

 C4/C5, No. (%)

14

11

 C5/C6, No. (%)

23

24

 C6/C7, No. (%)

3

1

 C7/T1, No. (%)

2

1

Average follow-up time(m)

28.37 ± 3.60

29.82 ± 3.25

.367

Re-operation rates

8.3% (4/48)

4.8% (2/42)

0.799